Paradigm Asset Management CO LLC Bristol Myers Squibb CO Transaction History

Paradigm Asset Management CO LLC

$266 Million
Q3 2024

A detailed history of Paradigm Asset Management CO LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 33,008 shares of BMY stock, worth $1.91 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

33,008

Previous 33,008 -0.0%

Holding current value

$1.91 Million

Previous $1.37 Million 24.67%

% of portfolio

0.64%

Previous 0.55%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $515,200 - $678,272	-12,800 Reduced 27.94%	33,008 $1.37 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $62,373 - $70,720	-1,300 Reduced 2.76%	45,808 $2.48 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $58,175 - $69,420	-1,200 Reduced 2.48%	47,108 $2.42 Million
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $138,936 - $155,352	-2,400 Reduced 4.73%	48,308 $2.8 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $3 Million - $3.33 Million	47,100 Added 1305.43%	50,708 $3.24 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $13,141 - $14,906	-200 Reduced 5.25%	3,608 $250,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $3.51 Million - $4.16 Million	-51,240 Reduced 93.08%	3,808 $273,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $104 - $61,472	-800 Reduced 1.43%	55,048 $3.91 Billion
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $159,764 - $175,956	2,200 Added 4.1%	55,848 $4.3 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $204,223 - $238,076	3,808 Added 7.64%	53,648 $3.34 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $142,008 - $166,344	-2,400 Reduced 4.59%	49,840 $2.95 Million
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $89,010 - $100,109	-1,500 Reduced 2.79%	52,240 $3.3 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $2.14 Million - $2.42 Million	37,000 Added 221.03%	53,740 $3.33 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $155,061 - $171,828	-2,700 Reduced 13.89%	16,740 $1.01 Million
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $213,798 - $249,951	-3,900 Reduced 16.71%	19,440 $1.14 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $41,828 - $54,561	850 Added 3.78%	23,340 $1.5 Million
Q3 2019 Nov 15, 2019	SELL	$42.77 - $50.71 $205,296 - $243,408	-4,800 Reduced 17.59%	22,490 $1.14 Million
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $220,869 - $244,233	4,950 Added 22.16%	27,290 $0
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $42,864 - $51,110	-950 Reduced 4.08%	22,340 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $48,760 - $63,230	1,000 Added 4.49%	23,290 $1.21 Million
Q3 2018 Nov 19, 2018	SELL	$55.19 - $62.25 $1.14 Million - $1.28 Million	-20,600 Reduced 48.03%	22,290 $0
Q1 2018 May 07, 2018	SELL	$59.92 - $68.98 $167,776 - $193,144	-2,800 Reduced 6.13%	42,890 $0
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $275,724 - $300,610	-4,600 Reduced 9.15%	45,690 $0
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $2.78 Million - $3.21 Million	50,290	50,290 $0

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.

Account

Paradigm Asset Management CO LLC Bristol Myers Squibb CO Transaction History